<DOC>
	<DOCNO>NCT00982423</DOCNO>
	<brief_summary>The investigator ' objective define effect decrease furosemide dose heart , kidney humoral function people compensate heart failure kidney dysfunction also people compensate heart failure without kidney dysfunction . Secondly , define humoral activation group .</brief_summary>
	<brief_title>The Effects Decreasing Lasix Dose Cardiorenal System</brief_title>
	<detailed_description>The broad objective protocol advance understanding pathophysiological mechanism human Cardiorenal Syndrome ( CRS ) specific emphasis upon biological interaction diuretic therapy , renin-angiotensin-aldosterone-system ( RAAS ) cyclic 3'-5'-guanosine monophosphate ( cGMP ) pathway .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Inclusion Criteria Subjects Compensated CHF without Renal Dysfunction : Left ventricular ejection fraction equal le 40 % assessed echocardiography , nuclear scan , MRI , leave ventriculogram within past 36 month . Stable New York Heart Association ( NYHA ) class II III symptom define : ) change NYHA symptom past 3 month ; b ) stable dos ACE inhibitor beta blocker digoxin furosemide angiotensin II receptor , type 1 ( AT1 ) blocker past 3 month ; c ) episode decompensated CHF past 6 month . Calculated creatinine clearance equal le 80 ml/min , use CockcroftGault formula assess within past 36 month confirmatory calculate creatinine clearance equal le 80 ml/min time enrollment . Inclusion Criteria Subjects Compensated CHF Renal Dysfunction : Left ventricular ejection fraction equal le 40 % assessed echocardiography , nuclear scan leave ventriculogram within past 36 month . Stable New York Heart Association ( NYHA ) class II III symptom define : ) change NYHA symptom past 3 month ; b ) stable dos ACE inhibitor beta blocker digoxin furosemide AT1 blocker past 3 month ; c ) episode decompensated CHF past 6 month . Calculated creatinine clearance equal le 60 ml/min great 20 ml/min , use CockcroftGault formula assess within past 36 month confirmatory calculate creatinine clearance equal le 60 ml/min great 20 ml/min time enrollment . Exclusion Criteria group : Prior diagnosis intrinsic renal disease include renal artery stenosis &gt; 50 % Peritoneal hemodialysis within 90 day anticipation dialysis ultrafiltration form require study period Patients take aldosterone antagonist Hospitalization decompensated CHF past 6 month Subjects diuretic besides furosemide Myocardial infarction within 6 month screen Unstable angina within 6 month screen evidence myocardial ischemia Significant valvular stenosis , hypertrophic , restrictive obstructive cardiomyopathy , constrictive pericarditis , primary pulmonary hypertension , biopsy proven active myocarditis Severe congenital heart disease Sustained ventricular tachycardia ventricular fibrillation within 14 day screen Second third degree heart block without permanent cardiac pacemaker Stroke within 3 month screen evidence significantly compromised central nervous system ( CNS ) perfusion Alanine Aminotransferase ( ALT ) result &gt; 1.5 time upper limit normal Serum sodium &lt; 125 milliequivalent ( mEq ) /dL &gt; 150 mEq/dL Serum potassium &lt; 3.5 mEq/dL &gt; 5.5 mEq/dL Serum digoxin level &gt; 2.0 ng/ml Hemoglobin &lt; 10 gm/dl Other acute chronic medical condition laboratory abnormality may increase risk associate study participation may interfere interpretation data Received investigational drug within 1 month prior dose Patients allergy iodine . Female subject pregnant breastfeeding In opinion investigator unlikely comply study protocol unsuitable reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>heart failure</keyword>
	<keyword>heart failure without kidney dysfunction</keyword>
</DOC>